Overview

Sequel seeks to build a portfolio of cardiovascular product candidates by in-licensing clinical stage compounds.

We are also pursuing partnerships for development and commercialization of our compounds outside of the United States.

If you would like to discuss partnership opportunities with Sequel, please contact us.